Formulations of Amlodipine: A Review

被引:22
作者
Sheraz, Muhammad Ali [1 ]
Ahsan, Syed Furqan [1 ]
Khan, Marium Fatima [1 ]
Ahmed, Sofia [1 ]
Ahmad, Iqbal [1 ]
机构
[1] Baqai Med Univ, Baqai Inst Pharmaceut Sci, 51 Deh Torr,Toll Plaza,Super Highway,Gadap Rd, Karachi 74600, Pakistan
关键词
D O I
10.1155/2016/8961621
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Amlodipine (AD) is a calcium channel blocker that is mainly used in the treatment of hypertension and angina. However, latest findings have revealed that its efficacy is not only limited to the treatment of cardiovascular diseases as it has shown to possess antioxidant activity and plays an important role in apoptosis. Therefore, it is also employed in the treatment of cerebrovascular stroke, neurodegenerative diseases, leukemia, breast cancer, and so forth either alone or in combination with other drugs. AD is a photosensitive drug and requires protection from light. A number of workers have tried to formulate various conventional and nonconventional dosage forms of AD. This review highlights all the formulations that have been developed to achieve maximum stability with the desired therapeutic action for the delivery of AD such as fast dissolving tablets, floating tablets, layered tablets, single-pill combinations, capsules, oral and transdermal films, suspensions, emulsions, mucoadhesive microspheres, gels, transdermal patches, and liposomal formulations.
引用
收藏
页数:11
相关论文
共 129 条
[1]   Review of bilayer tablet technology [J].
Abebe, Admassu ;
Akseli, Ilgaz ;
Sprockel, Omar ;
Kottala, Niranjan ;
Cuitino, Alberto M. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2014, 461 (1-2) :549-558
[2]   Mechanistic characterization of bilayer tablet formulations [J].
Akseli, Ilgaz ;
Abebe, Admassu ;
Sprockel, Omar ;
Cuitino, Alberto M. .
POWDER TECHNOLOGY, 2013, 236 :30-36
[3]   Single-pill combination therapy in the initial treatment of marked hypertension: a propensity-matched analysis [J].
Angeloni, Emiliano ;
Vitaterna, Angelo ;
Lombardo, Paola ;
Pirelli, Michele ;
Refice, Simone .
CLINICAL AND EXPERIMENTAL HYPERTENSION, 2015, 37 (05) :404-410
[4]  
[Anonymous], 2011, BRIT NATL FORMULARY
[5]  
[Anonymous], 2011, PHARM LETT
[6]  
[Anonymous], 2009, COMPLETE DRUG REFERE
[7]   Stability of amlodipine besylate and atenolol in multi-component tablets of mono-layer and bi-layer types [J].
Aryal, Sajjan ;
Skalko-Basnet, Natasa .
ACTA PHARMACEUTICA, 2008, 58 (03) :299-308
[8]   Efficacy and tolerability of the single-pill combination of aliskiren 300 mg/amlodipine 10 mg in hypertensive patients not controlled by olmesartan 40 mg/amlodipine 10 mg [J].
Axthelm, Christoph ;
Sieder, Christian ;
Meister, Franziska ;
Kaiser, Edelgard .
CURRENT MEDICAL RESEARCH AND OPINION, 2012, 28 (01) :69-78
[9]   Effects of Single Pill-Based Combination Therapy of Amlodipine and Atorvastatin on Within-Visit Blood Pressure Variability and Parameters of Renal and Vascular Function in Hypertensive Patients with Chronic Kidney Disease [J].
Azushima, Kengo ;
Uneda, Kazushi ;
Tamura, Kouichi ;
Wakui, Hiromichi ;
Ohsawa, Masato ;
Kobayashi, Ryu ;
Dejima, Toru ;
Kanaoka, Tomohiko ;
Maeda, Akinobu ;
Toya, Yoshiyuki ;
Umemura, Satoshi .
BIOMED RESEARCH INTERNATIONAL, 2014, 2014
[10]  
Baser Onur, 2011, J Med Econ, V14, P576, DOI 10.3111/13696998.2011.596873